Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Cartesian Therapeutics Inc (NASDAQ: RNAC) closed at $16.92 in the last session, down -1.40% from day before closing price of $17.16. In other words, the price has decreased by -$1.40 from its previous closing price. On the day, 0.14 million shares were traded. RNAC stock price reached its highest trading level at $17.255 during the session, while it also had its lowest trading level at $16.59.
Ratios:
We take a closer look at RNAC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.70 and its Current Ratio is at 10.70. In the meantime, Its Debt-to-Equity ratio is 19.53 whereas as Long-Term Debt/Eq ratio is at 15.84.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 19, 2024, initiated with a Buy rating and assigned the stock a target price of $42.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 06 ’25 when Kurtoglu Metin sold 2,458 shares for $16.83 per share. The transaction valued at 41,374 led to the insider holds 62,258 shares of the business.
Kurtoglu Metin sold 2,417 shares of RNAC for $40,417 on Jan 03 ’25. The Chief Technology Officer now owns 64,716 shares after completing the transaction at $16.72 per share. On Jan 06 ’25, another insider, Miljkovic Milos, who serves as the Chief Medical Officer of the company, sold 948 shares for $16.83 each. As a result, the insider received 15,957 and left with 35,393 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RNAC now has a Market Capitalization of 430020096 and an Enterprise Value of 225473072. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.08 while its Price-to-Book (P/B) ratio in mrq is 537.65. Its current Enterprise Value per Revenue stands at 4.703 whereas that against EBITDA is -5.671.
Stock Price History:
Over the past 52 weeks, RNAC has reached a high of $41.87, while it has fallen to a 52-week low of $11.66. The 50-Day Moving Average of the stock is -12.62%, while the 200-Day Moving Average is calculated to be -14.62%.
Shares Statistics:
According to the various share statistics, RNAC traded on average about 120.29K shares per day over the past 3-months and 101020 shares per day over the past 10 days. A total of 23.90M shares are outstanding, with a floating share count of 10.69M. Insiders hold about 58.44% of the company’s shares, while institutions hold 23.70% stake in the company. Shares short for RNAC as of 1734048000 were 1796563 with a Short Ratio of 14.94, compared to 1731628800 on 1859311. Therefore, it implies a Short% of Shares Outstanding of 1796563 and a Short% of Float of 11.26.
